Patient Guides: ESMO Patient Guides Compilation (Luxembourg): Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
'''Primary purpose:''' To translate complex medical language into understandable information for patients. | '''Primary purpose:''' To translate complex medical language into understandable information for patients. | ||
'''Sponsor, manager or home institution:''' European Society for Medical Oncology. | '''Sponsor, manager or home institution:''' [[dataOwner::European Society for Medical Oncology]]. | ||
'''Type of information:''' Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others. [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-french Click here to learn more]. | '''Type of information:''' Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others. [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-french Click here to learn more]. | ||
Revision as of 17:19, 21 May 2024
Go back to Luxembourg page
Primary purpose: To translate complex medical language into understandable information for patients.
Sponsor, manager or home institution: European Society for Medical Oncology.
Type of information: Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others. Click here to learn more.
Cancer areas of interest: C00-C97: All cancer types. Cancer Treatment During the COVID-19 Pandemic; Immunotherapy Side Effects and Their Management; Personalized Medicine; Survival; Colorectal Cancer; Endometrial Cancer; Stomach Cancer; Gliomas; AML; CML; Follicular Lymphoma; Bone Sarcomas; Non-Small Cell Lung Cancer (NSCLC); Head and Neck Cancer; Soft Tissue Sarcomas.
Access to information: Click here to access.
